|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Inflammasomes: Promising Targets In Therapeutic Strategies For Covid 19 |
| Authors Name: | Omkar Deshmukh , Smita Nayak , Vaidhun Bhaskar |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_204114
|
| Published Paper Id: | IJNRD2308266 |
| Published In: | Volume 8 Issue 8, August-2023 |
| DOI: | |
| Abstract: | Clinical symptoms caused by SARS-CoV-2, the virus that was responsible for the spread of COVID-19, vary from no symptoms to severe pneumonia and death. Several studies point to the critical role of inflammatory cytokines in initiating and exacerbating the immune response, leading to the overproduction of cytokines as well as chemokines and ultimately resulting in a cytokine storm. A significant contributing factor to the uncontrolled pro-inflammatory response to the viral infection is the activation of the NLRP3 inflammasome, a part of the innate immune system. For the creation of therapeutic approaches to treat COVID-19, this inflammasome can be employed as a target. The NLRP3 inflammasome's structure is described in this review, along with the many methods that have been used to target it. |
| Keywords: | NLRP3 inflammasomes, Anakinra, Lipoxin, Cytokines, Ginseng. |
| Cite Article: | "Inflammasomes: Promising Targets In Therapeutic Strategies For Covid 19", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 8, page no.c497-c502, August-2023, Available :http://www.ijnrd.org/papers/IJNRD2308266.pdf |
| Downloads: | 000118753 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2308266 Registration ID: 204114 Published In: Volume 8 Issue 8, August-2023 DOI (Digital Object Identifier): Page No: c497-c502 Country: Navi Mumbai, Maharashtra, India Research Area: Health Science Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2308266 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2308266 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn